Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 245
Filtrar
1.
Nanoscale Adv ; 1(9): 3680-3685, 2019 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-36133532

RESUMEN

MXenes are a rapidly growing family of 2D materials that exhibit a highly versatile structure and composition, allowing for significant tuning of the materials properties. These properties are, however, ultimately limited by the surface terminations, which are typically a mixture of species, including F and O that are inherent to the MXene processing. Other and robust terminations are lacking. Here, we apply high-resolution scanning transmission electron microscopy (STEM), corresponding image simulations and first-principles calculations to investigate the surface terminations on MXenes synthesized from MAX phases through Lewis acidic melts. The results show that atomic Cl terminates the synthesized MXenes, with mere residual presence of other termination species. Furthermore, in situ STEM-electron energy loss spectroscopy (EELS) heating experiments show that the Cl terminations are stable up to 750 °C. Thus, we present an attractive new termination that widely expands the MXenes' functionalization space and enables new applications.

2.
Allergy ; 73(5): 1053-1063, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29319193

RESUMEN

BACKGROUND: Impaired antiviral interferon expression may be involved in asthma exacerbations commonly caused by rhinovirus infections. Allergy is a known risk factor for viral-induced asthma exacerbation, but little is known whether allergens may affect interferon responses. OBJECTIVE: Our hypothesis is that house dust mite (HDM) impairs viral stimulus-induced antiviral signalling. METHODS: Experimental asthma exacerbations were produced in vitro in human bronchial epithelial cells (HBECs) and in mice using sequential challenges with HDM and a viral infection mimic, Poly(I:C). We examined rhinovirus pattern recognition receptors (PRRs) signalling pathways and potential mechanisms of impaired interferon response. RESULTS: HBECs and mice exposed to HDM prior to Poly(I:C) exhibited a reduced antiviral response compared to Poly(I:C) alone, including reduced IFN-ß, IFN-λ, TLR3, RIG-I, MDA5, IRF-3 and IRF-7. Heat inactivation of HDM partially restored the TLR3-induced interferon response in vitro and in vivo. Our HBEC-data further showed that HDM directly affects TLR3 signalling by targeting the receptor glycosylation level. CONCLUSIONS: Direct effects of allergens such as HDM on PRRs can present as potential mechanism for defective antiviral airway responses. Accordingly, therapeutic measures targeting inhibitory effects of allergens on antiviral PRRs may find use as a strategy to boost antiviral response and ameliorate exacerbations in asthmatic patients.


Asunto(s)
Asma/inmunología , Interferones/biosíntesis , Infecciones por Picornaviridae/inmunología , Pyroglyphidae/inmunología , Receptor Toll-Like 3/inmunología , Animales , Asma/virología , Células Cultivadas , Células Epiteliales/inmunología , Células Epiteliales/virología , Humanos , Hipersensibilidad/inmunología , Inductores de Interferón/inmunología , Interferones/inmunología , Ratones , Ratones Endogámicos C57BL , Infecciones por Picornaviridae/complicaciones , Poli I-C/inmunología , Receptores de Reconocimiento de Patrones/inmunología , Rhinovirus
3.
J Nutr Health Aging ; 21(9): 1057-1064, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29083448

RESUMEN

OBJECTIVES: The aim is to explore the effects of antecedent, structural and process quality indicators of nutritional care practice on meal satisfaction and screened nutritional status among older adults in residential care homes. DESIGN: Data for this Swedish cross-sectional study regarding older adults living in residential care homes were collected by i) a national questionnaire, ii) records from the quality registry Senior Alert, iii) data from an Open Comparison survey of elderly care in 2013/2014. The data represented 1154 individuals in 117 of 290 Swedish municipalities. MEASUREMENTS: Meal satisfaction (%) and adequate nutritional status, screened by the Mini Nutritional Assessment Short Form (MNA-SF), were the two outcome variables assessed through their association with population density of municipalities and residents' age, together with 12 quality indicators pertaining to structure and process domains in the Donabedian model of care. RESULTS: Meal satisfaction was associated with rural and urban municipalities, with the structure quality indicators: local food policies, private meal providers, on-site cooking, availability of clinical/community dietitians, food service dietitians, and with the process quality indicators: meal choice, satisfaction surveys, and 'meal councils'. Adequate nutritional status was positively associated with availability of clinical/community dietitians, and energy and nutrient calculated menus, and negatively associated with chilled food production systems. CONCLUSION: Municipality characteristics and structure quality indicators had the strongest associations with meal satisfaction, and quality indicators with local characteristics emerge as important for meal satisfaction. Nutritional competence appears vital for residents to be well-nourished.


Asunto(s)
Evaluación Nutricional , Apoyo Nutricional/métodos , Anciano de 80 o más Años , Estudios Transversales , Femenino , Humanos , Masculino , Encuestas y Cuestionarios
6.
Leukemia ; 30(9): 1853-60, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27133821

RESUMEN

Dasatinib (DAS) and interferon-α have antileukemic and immunostimulatory effects and induce deep responses in chronic myeloid leukemia (CML). We assigned 40 newly diagnosed chronic-phase CML patients to receive DAS 100 mg o.d. followed by addition of pegylated interferon-α2b (PegIFN) after 3 months (M3). The starting dose of PegIFN was 15 µg/week and it increased to 25 µg/week at M6 until M15. The combination was well tolerated with manageable toxicity. Of the patients, 84% remained on PegIFN at M12 and 91% (DAS) and 73% (PegIFN) of assigned dose was given. Only one patient had a pleural effusion during first year, and three more during the second year. After introduction of PegIFN we observed a steep increase in response rates. Major molecular response was achieved in 10%, 57%, 84% and 89% of patients at M3, M6, M12 and M18, respectively. At M12, MR(4) was achieved by 46% and MR(4.5) by 27% of patients. No patients progressed to advanced phase. In conclusion, the combination treatment appeared safe with very promising efficacy. A randomized comparison of DAS±PegIFN is warranted.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/toxicidad , Dasatinib/administración & dosificación , Interferón-alfa/administración & dosificación , Leucemia Mieloide de Fase Crónica/tratamiento farmacológico , Polietilenglicoles/administración & dosificación , Adolescente , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Femenino , Humanos , Interferón alfa-2 , Masculino , Persona de Mediana Edad , Derrame Pleural , Proteínas Recombinantes/administración & dosificación , Inducción de Remisión , Resultado del Tratamiento , Adulto Joven
7.
Nanoscale ; 8(13): 7056-67, 2016 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-26960813

RESUMEN

Tin oxide is considered to be one of the most promising semiconductor oxide materials for use as a gas sensor. However, a simple route for the controllable build-up of nanostructured, sufficiently pure and hierarchical SnO2 structures for gas sensor applications is still a challenge. In the current work, an aqueous SnO2 nanoparticulate precursor sol, which is free of organic contaminants and sorbed ions and is fully stable over time, was prepared in a highly reproducible manner from an alkoxide Sn(OR)4 just by mixing it with a large excess of pure neutral water. The precursor is formed as a separate liquid phase. The structure and purity of the precursor is revealed using XRD, SAXS, EXAFS, HRTEM imaging, FTIR, and XRF analysis. An unconventional approach for the estimation of the particle size based on the quantification of the Sn-Sn contacts in the structure was developed using EXAFS spectroscopy and verified using HRTEM. To construct sensors with a hierarchical 3D structure, we employed an unusual emulsification technique not involving any additives or surfactants, using simply the extraction of the liquid phase, water, with the help of dry butanol under ambient conditions. The originally generated crystalline but yet highly reactive nanoparticles form relatively uniform spheres through self-assembly and solidify instantly. The spheres floating in butanol were left to deposit on the surface of quartz plates bearing sputtered gold electrodes, producing ready-for-use gas sensors in the form of ca. 50 µm thick sphere-based-films. The films were dried for 24 h and calcined at 300 °C in air before use. The gas sensitivity of the structures was tested in the temperature range of 150-400 °C. The materials showed a very quickly emerging and reversible (20-30 times) increase in electrical conductivity as a response to exposure to air containing 100 ppm of H2 or CO and short (10 s) recovery times when the gas flow was stopped.

8.
J Intern Med ; 278(4): 335-53, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26123389

RESUMEN

In response to the 2009-2010 influenza A(H1N1)pdm09 pandemic, a mass vaccination programme with the AS03-adjuvanted influenza A(H1N1) vaccine Pandemrix was initiated in Sweden. Unexpectedly, there were a number of narcolepsy cases amongst vaccinated children and adolescents reported. In this review, we summarize the results of a joint cross-disciplinary national research effort to investigate the adverse reaction signal from the spontaneous reporting system and to better understand possible causative mechanisms. A three- to fourfold increased risk of narcolepsy in vaccinated children and adolescents was verified by epidemiological studies. Of importance, no risk increase was observed for the other neurological and autoimmune diseases studied. Genetic studies confirmed the association with the allele HLA-DQB1*06:02, which is known to be related to sporadic narcolepsy. Furthermore, a number of studies using cellular and molecular experimental models investigated possible links between influenza vaccination and narcolepsy. Serum analysis, using a peptide microarray platform, showed that individuals who received Pandemrix exhibited a different epitope reactivity pattern to neuraminidase and haemagglutinin, as compared to individuals who were infected with H1N1. Patients with narcolepsy were also found to have increased levels of interferon-gamma production in response to streptococcus-associated antigens. The chain of patient-related events and the study results emerging over time were subjected to intense nationwide media attention. The importance of transparent communication and collaboration with patient representatives to maintain public trust in vaccination programmes is also discussed in the review. Organizational challenges due to this unexpected event delayed the initiation of some of the research projects, still the main objectives of this joint, cross-disciplinary research effort were reached, and important insights were acquired for future, similar situations in which a fast and effective task force may be required to evaluate vaccination-related adverse events.


Asunto(s)
Subtipo H1N1 del Virus de la Influenza A , Vacunas contra la Influenza/efectos adversos , Gripe Humana/prevención & control , Narcolepsia/etiología , Vacunación/efectos adversos , Adolescente , Niño , Epítopos/inmunología , Hemaglutininas/inmunología , Humanos , Inmunohistoquímica , Interferón gamma/biosíntesis , Relaciones Interprofesionales , Narcolepsia/genética , Narcolepsia/inmunología , Neuraminidasa/inmunología , Fragmentos de Péptidos/biosíntesis , Investigación , Streptococcus/inmunología , Suecia
10.
Med Oncol ; 31(8): 66, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24965535

RESUMEN

Even in the tyrosine kinase inhibitor era, allogeneic hematopoietic stem cell transplantation (HSCT) is regarded as standard care for adult Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL). In this retrospective national study, we have reviewed the outcome after HSCT in Sweden for adult Ph-positive ALL between 2000 and 2009. In total, 51 patients with median age 42 (range 20-66) years underwent HSCT. Mainly allogeneic HSCT was performed (24 related donor, 24 unrelated donor and one cord blood), and only two patients were treated with an autologous HSCT. The 5-year OS was 51 (37-64) %. The probabilities of morphological relapse and non-relapse mortality (NRM) at 5 years were 36 (23-49) and 18 (9-29) %, respectively. For the allogeneic transplanted, the 5-year OS was for patients <40 years 70 (50-90) % and for patients ≥40 years 34 (16-52) %, p = 0.002. The 5-year probability of NRM was for patients <40 years 10 (2-28) % compared to 25 (11-42) % for patients ≥40 years (p = 0.04). Patients with chronic graft-versus-host disease (GVHD) had a 5-year morphological relapse probability of 20 (6-40) % compared to 59 (35-77) % for patients without chronic GVHD (p = 0.03). Age ≥40 years and the absence of chronic GVHD were confirmed as independent negative prognostic factors for relapse and non-relapse mortality in a multivariate analysis although the impact of chronic GVHD was significant only in the older age cohort.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Adulto , Anciano , Autoinjertos , Benzamidas/uso terapéutico , Femenino , Proteínas de Fusión bcr-abl/genética , Enfermedad Injerto contra Huésped , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Mesilato de Imatinib , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/tratamiento farmacológico , Recurrencia Local de Neoplasia/epidemiología , Piperazinas/uso terapéutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/mortalidad , Inhibidores de Proteínas Quinasas/uso terapéutico , Pirimidinas/uso terapéutico , Tasa de Supervivencia , Suecia , Trasplante Homólogo/efectos adversos , Resultado del Tratamiento , Adulto Joven
12.
J Intern Med ; 275(2): 172-90, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24134219

RESUMEN

OBJECTIVES: To investigate the association between vaccination with Pandemrix and risk of selected neurological and immune-related diseases including narcolepsy. DESIGN: Population-based prospective cohort study using data from regional vaccination registries and national health registries. SETTING: Seven healthcare regions in Sweden comprising 61% of the Swedish population. SUBJECTS: Study population of 3,347,467 vaccinated and 2,497,572 nonvaccinated individuals (vaccination coverage ≈ 60%) followed between 2009 and 2011 for 6.9 million person-years after exposure and 6.0 million person-years without exposure. MAIN OUTCOME MEASURE AND ANALYSIS: First recorded diagnosis of neurological and immune-related diseases. Relative risks [hazard ratios (HRs) with 95% confidence intervals (CIs)] assessed using Cox regression, adjusted for covariates. RESULTS: For all selected neurological and immune-related outcomes under study, other than allergic vaccine reactions (for which we verified an expected increase in risk) and narcolepsy, HRs were close to 1.0 and always below 1.3. We observed a three-fold increased risk of a diagnosis of narcolepsy (HR: 2.92, 95% CI: 1.78-4.79; that is, four additional cases per 100,000 person-years) in individuals ≤ 20 years of age at vaccination and a two-fold increase (HR: 2.18, 95% CI: 1.00-4.75) amongst young adults between 21 and 30 years of age. The excess risk declined successively with increasing age at vaccination; no increase in risk was seen after 40 years of age. CONCLUSIONS: For a large number of selected neurological and immune-related diseases, we could neither confirm any causal association with Pandemrix nor refute entirely a small excess risk. We confirmed an increased risk for a diagnosis of narcolepsy in individuals ≤ 20 years of age and observed a trend towards an increased risk also amongst young adults between 21 and 30 years.


Asunto(s)
Enfermedades del Sistema Inmune/inducido químicamente , Vacunas contra la Influenza/efectos adversos , Narcolepsia/inducido químicamente , Enfermedades del Sistema Nervioso/inducido químicamente , Vacunación/efectos adversos , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Enfermedades Autoinmunes del Sistema Nervioso/inducido químicamente , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Lactante , Vacunas contra la Influenza/administración & dosificación , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Sistema de Registros , Riesgo , Suecia/epidemiología
13.
Allergy ; 69(3): 348-58, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24283976

RESUMEN

BACKGROUND: Rhinovirus infection or dsRNA stimulation increased thymic stromal lymphopoietin (TSLP), an upstream pro-allergic cytokine, in asthmatic bronchial epithelial cells. We hypothesized that dsRNA challenges superimposed on established experimental allergic asthma constitute a useful exacerbation model. We further hypothesized that TSLP is induced at dsRNA- and rhinoviral infection-induced exacerbations. METHODS: Allergic mice were challenged with OVA followed by three daily intranasal challenges with dsRNA or saline. Bronchoalveolar lavage fluid (BALF) was analysed for total protein, lactate dehydrogenase (LDH), CXCL1/KC, CCL2/MCP-1 and differential cell counts. Lung tissue histology, neutrophils and TSLP, TNF-α, IFN-ß and IFN-λ mRNA were examined. Alternatively, allergen-challenged mice received intranasal rhinovirus-(RV)-1B followed by lung TSLP immunostaining. RESULTS: In mice with allergic airway inflammation, dsRNA challenges caused a significant exacerbation increasing lung tissue inflammation score and tissue neutrophilia. Bronchoalveolar lavage fluid neutrophils, total protein, LDH, CXCL1/KC and CCL2/MCP-1 were also increased (P < 0.01), and so were lung tissue expressions of TNF-α, IFN-λ and TSLP (P < 0.01), but IFN-ß was not increased. TSLP, IFN-λ and LDH were not increased by allergen or dsRNA challenges alone, but increased exclusively at exacerbations. RV1B infection-induced exacerbation also increased lung tissue TSLP (P < 0.05). CONCLUSIONS: dsRNA-induced exacerbation in mice with experimental asthma involved general inflammation, cytokines and interferons, in agreement with previous observations in exacerbating human asthma. Additionally, both dsRNA and RV1B infection increased lung TSLP exclusively at exacerbations. Our data suggest that dsRNA challenges superimposed on allergic inflammation are suited for pharmacological studies of asthma exacerbations including the regulation of lung tissue TSLP, TNF-α, IFN-ß and IFN-λ.


Asunto(s)
Asma/genética , Asma/inmunología , Citocinas/genética , Pulmón/inmunología , Pulmón/metabolismo , Neutrófilos/inmunología , ARN Bicatenario/inmunología , Rhinovirus/inmunología , Administración Intranasal , Animales , Modelos Animales de Enfermedad , Expresión Génica , Interferón gamma/genética , Pulmón/patología , Ratones , Ovalbúmina/inmunología , ARN Bicatenario/administración & dosificación , Factor de Necrosis Tumoral alfa/genética , Linfopoyetina del Estroma Tímico
14.
Environ Pollut ; 180: 19-26, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23727563

RESUMEN

Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo-p-furans (PCDD/Fs) were analysed in soil from a Swedish sawmill site where chlorophenols (CPs) had been used more than 40 years ago. The most contaminated area at the site was the preservation subarea where the PCDD/F WHO2005-TEQ level was 3450 times higher than the current Swedish guideline value of 200 ng TEQ/kg soil for land for industrial use. It was also shown that a fire which destroyed the sawmill might have affected the congener distribution at the concerned areas. To get a broader picture of the contamination both GIS (spatial interpolation analysis) and multivariate data analysis (PCA) were applied to visualize and compare PCDD/F levels as well as congener distributions at different areas at the site. It is shown that GIS and PCA are powerful tools in decisions on future investigations, risk assessments and remediation of contaminated sites.


Asunto(s)
Benzofuranos/análisis , Monitoreo del Ambiente/métodos , Contaminación Ambiental/estadística & datos numéricos , Dibenzodioxinas Policloradas/análogos & derivados , Polímeros/análisis , Contaminantes del Suelo/análisis , Sistemas de Información Geográfica , Industrias , Dibenzodioxinas Policloradas/análisis , Análisis de Componente Principal , Suelo/química , Suecia
15.
Waste Manag ; 29(2): 506-12, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18571397

RESUMEN

In order to manage municipal solid waste incineration (MSWI) bottom ash safely, risk assessments, including the prediction of leaching under different field conditions, are necessary. In this study, the influence of salt or dissolved organic matter (DOM) in the influent on metal leaching from MSWI bottom ash was investigated in a column experiment. The presence of salt (0.1M NaCl) resulted in a small increase of As leaching, whereas no impact on leachate concentration was found when lakewater DOM (35.1mg/l dissolved organic carbon) was added. Most of the added DOM was retained within the material. Further, X-ray spectroscopy revealed that Cu(II) was the dominating form of Cu and that it probably occurred as a CuO-type mineral. The Cu(2+) activity in the MSWI bottom ash leachate was most likely determined by the dissolution of CuO together with the formation of Cu-DOM complexes and possibly also by adsorption to (hydr)oxide minerals. The addition of lake DOM in the influent resulted in lower saturation indices for CuO in the leachates, which may be due to slow CuO dissolution kinetics in combination with strong Cu-DOM complexation.


Asunto(s)
Incineración , Metales/química , Compuestos Orgánicos/química , Cloruro de Sodio/química , Contaminantes Ambientales , Solubilidad
16.
J Hazard Mater ; 158(2-3): 401-9, 2008 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-18329799

RESUMEN

Chromium(III), copper(II), zinc(II), cadmium(II), mercury(II) and lead(II) cations are among the most common heavy metal pollutants in industrial waste waters. In our continued work on cost effective wastewater heavy metal removal agents and methods using local material, this study examines the interactions of chromium(III), copper(II), zinc(II), cadmium(II), mercury(II) and lead(II) cations with natural mixed clay minerals from Tundulu in Malawi using extended X-ray absorption fine structure (EXAFS) spectroscopy. The mixed clays were previously characterised and found to contain illite, low ordered kaolinite, mixed layer minerals and the non-clay mineral carbonate fluoroapatite with a mean pH(PZC) of 9.63. The EXAFS analyses provided qualitative evidence that oxygen atoms occupy the first coordination shells in all the studied central atoms. The metal species on the clay mineral surfaces seem to be adsorbates and/or precipitates of hydrolysis products. Chromium(III) forms a polynuclear hydrolysis complex on the mineral surface with Cr-O bond and Cr...Cr distances of 2.00 and 3.03 A, respectively, which is indicative of a chain structure with edge sharing CrO(6) octahedra. Copper(II) is bound to phosphate groups on the surface at low pH and has a first shell of coordinated oxygen atoms with Jahn-Teller distortion as revealed by different Cu-O bonds of 1.96 A for the equatorial ones, at 2.30 and 2.65 A for the axial oxygens, and a Cu-P distance at 3.29 A is distinguished as well. Upon treatment at neutral pH copper(I) oxide seems to be the main precipitation product on the clay surface. At neutral pH zinc(II) forms also polynuclear hydrolysis complexes with Zn-O bond and Zn...Zn distances of 2.01 and 3.11A, respectively, which shows the presence of edge sharing ZnO(4) tetrahedra. Cadmium(II) is adsorbed to the clay surfaces as a six-coordinated CdO(6) complex in octahedral fashion, but it is not possible to distinguish if cadmium is hydrated or partly hydrolysed. Mercury(II) is present as linear O-Hg-O units but without any observable Hg...Hg distance at high pH showing that mercury(II) is hydrolysed but not present as mercury(II) oxide. At low pH, linear O-Hg-Hg-O units are present showing that mercury(II) is reduced to mercury(I). No precise chemical environment around the lead(II) could be obtained for the lead(II) treated clays due to formation of different hydrolysis structures with multiple coordination numbers by lead(II) salts on the mixed clays.


Asunto(s)
Silicatos de Aluminio , Metales Pesados/química , Análisis Espectral/métodos , Adsorción , Arcilla , Malaui , Rayos X
17.
Pharmacoepidemiol Drug Saf ; 17(5): 475-84, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18322905

RESUMEN

PURPOSE: Only randomized clinical trials (RCTs) are deemed suitable to determine causality, as epidemiological studies are considered not 'robust'. The objective of this study was to evaluate whether causality should remain the only consideration with drug toxicity signals. Cyclooxygenase-2 (Cox-2) inhibitors provided an example. METHODS: Our study population included patients aged 40+ years prescribed Cox-2 inhibitors in the General Practice Research Database (GPRD) (N = 150 000). We estimated the risks of upper gastrointestinal (GI) events and myocardial infarction (MI). Attributable risks were estimated using simulation methodology based on various hypothetical scenarios. RESULTS: The risk-benefit profile was strongly related to the rate of GI events. With a RCT incidence, the GI benefits would exceed MI risks. With a 'real-life' GI incidence, the benefits did not exceed the risks substantially. The onset and offset of drug effects also predicted the magnitude of both risks and benefits. If risks and benefits occurred in different sub-groups, the risk-benefit profile varied substantially. Also, it was found that any restriction of use to patients at high risk of drug toxicity may not improve the risk-benefit profile when this restriction affected patients who would benefit most. CONCLUSIONS: We conclude that rigid classification of evidence is not appropriate in the monitoring of risks and benefits and all valid study evidence--not only that derived from a RCT--needs to be included. The first priority should be to consider the potential impact of a drug toxicity signal.


Asunto(s)
Inhibidores de la Ciclooxigenasa 2/efectos adversos , Métodos Epidemiológicos , Selección de Paciente , Adulto , Anciano , Causalidad , Celecoxib , Simulación por Computador , Bases de Datos Factuales , Femenino , Enfermedades Gastrointestinales/inducido químicamente , Enfermedades Gastrointestinales/epidemiología , Humanos , Lactonas/efectos adversos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/inducido químicamente , Infarto del Miocardio/epidemiología , Pirazoles/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo/métodos , Sulfonamidas/efectos adversos , Sulfonas/efectos adversos
18.
Int J Epidemiol ; 37(2): 405-13, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18263647

RESUMEN

BACKGROUND: Selective cyclooxygenase-2 (Cox-2) inhibitors, developed to reduce the risk of NSAID-related gastrointestinal (GI) complications, have been associated with an increased risk of cardiovascular events. Our objective was to determine the balance of potential harm and benefit related to Cox-2 inhibitors' exposure. METHODS: The study population included patients aged 40+ years who received a prescription for Cox-2 inhibitors and were included in the General Practice Research Database. The incidence of upper GI events, myocardial infarction (MI) and stroke was estimated in this cohort. It was assumed that patients had experienced the upper GI and cardiovascular effects, as observed in clinical trials [relative rate (RR) of 0.49 for upper GI and 1.86 for MI]. Simulation methodology was used to estimate attributable risks, i.e. the difference between exposed and unexposed event probabilities. RESULTS: The study population included 155,439 Cox-2 users. The number of upper GI events prevented by Cox-2 inhibitors was 179, while the number of excess MI cases was 83 per 10,000 patients treated for 4 years. A strong association was found between extent of GI benefit and cardiovascular harm. There was a large difference in the frequency of benefit over harm in only 6% of the patients (difference of 1% or more); 23% of the patients had more harm than benefit, including those with a history of ischaemic heart disease. CONCLUSIONS: The benefit of Cox-2 inhibitors in reducing the frequency of upper GI events may be offset by their cardiovascular harm, particularly in patients with risk factors for cardiovascular disease.


Asunto(s)
Enfermedades Cardiovasculares/inducido químicamente , Inhibidores de la Ciclooxigenasa 2/efectos adversos , Adulto , Anciano , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/uso terapéutico , Estudios de Cohortes , Simulación por Computador , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Bases de Datos Factuales , Europa (Continente) , Medicina Familiar y Comunitaria , Femenino , Enfermedades Gastrointestinales/inducido químicamente , Enfermedades Gastrointestinales/prevención & control , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Infarto del Miocardio/inducido químicamente , Probabilidad , Vigilancia de Productos Comercializados/métodos , Riesgo , Accidente Cerebrovascular/inducido químicamente , Resultado del Tratamiento
19.
Hum Reprod ; 21(5): 1237-42, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16431901

RESUMEN

BACKGROUND: Several observations of the coexistence of endometriosis and cancer have been published. One study concerning endometriosis patients from 1969 to 1986 showed an overall relative cancer risk of 1.2 and relative risks for breast cancer, ovarian cancer and non-Hodgkin's lymphoma to be 1.3, 1.9 and 1.8, respectively. The aim of this study was to see whether these risk ratios stand in an extended study with longer follow-up. METHODS: Women discharged from a hospital, with a diagnosis of endometriosis from 1969 to 2000, were identified using the National Swedish Inpatient Register. Data were linked to the National Swedish Cancer Register to identify cases of cancer. Data on hysterectomies and oophorectomies were available. Standardized incidence ratios (SIR) were calculated. RESULTS: 64 492 women entered the study. First year of follow-up was excluded, leaving 3349 cases of cancer. There was no increased overall risk of cancer [SIR 1.04, 95% CI 1.00-1.07]. Elevated risks were found for ovarian cancer (SIR 1.43, 95% CI 1.19-1.71), endocrine tumours (SIR 1.36, 95% CI 1.15-1.61), non-Hodgkin's lymphoma (SIR 1.24, 95% CI 1.02-1.49) and brain tumours (SIR 1.22, 95% CI 1.04-1.41). Women with early diagnosed and long-standing endometriosis had a higher risk of ovarian cancer, with SIR of 2.01 and 2.23, respectively. The average age at endometriosis diagnosis was 39.4, indicating that there are the moderate/severe cases that are included in this study. Women who had a hysterectomy before or at the time of the endometriosis diagnosis did not show an increased risk of ovarian cancer. CONCLUSION: Women with endometriosis have an increased risk of some malignancies, particularly ovarian cancer, and the risk increases with early diagnosed or long-standing disease. Hysterectomy may have a preventive effect against ovarian cancer.


Asunto(s)
Endometriosis/complicaciones , Enfermedades del Ovario/complicaciones , Neoplasias Ováricas/epidemiología , Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Neoplasias/complicaciones , Neoplasias/epidemiología , Neoplasias Ováricas/complicaciones , Riesgo , Suecia/epidemiología
20.
J Clin Microbiol ; 42(8): 3635-43, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15297509

RESUMEN

All episodes of Clostridium difficile associated diarrhea (CDAD) diagnosed in a defined population of 274,000 including one tertiary and two primary hospitals and their catchment areas were studied during 12 months. The annual CDAD incidence in the county was 97 primary episodes per 100,000, and 78% of all episodes were classified as hospital associated with a mean incidence of 5.3 (range, 1.4 to 6.5) primary episodes per 1,000 admissions. The incidence among hospitalized individuals was 1,300-fold higher than that in the community (33,700 versus 25 primary episodes per 100,000 persons per year), reflecting a 37-fold difference in antibiotic consumption (477 versus 13 defined daily doses [DDD]/1,000 persons/day) and other risk factors. Three tertiary hospital wards with the highest incidence (13 to 36 per 1,000) had CDAD patients of high age (median age of 80 years versus 70 years for other wards, P < 0.001), long hospital stay (up to 25 days versus 4 days), or a high antibiotic consumption rate (up to 2,427 versus 421 DDD/1,000 bed days). PCR ribotyping of C. difficile isolates available from 330 of 372 CDAD episodes indicated nosocomial acquisition of the strain in 17 to 27% of hospital-associated cases, depending on the time interval between index and secondary cases allowed (2 months or up to 12 months), and only 10% of recurrences were due to a new strain of C. difficile (apparent reinfection). In other words, most primary and recurring episodes were apparently caused by the patient's endogenous strain rather than by one of hospital origin. Typing also indicated that a majority of C. difficile strains belonged to international serotypes, and the distribution of types was similar within and outside hospitals and in primary and relapsing CDAD. However, type SE17 was an exception, comprising 22% of hospital isolates compared to 6% of community isolates (P = 0.008) and causing many minor clusters and a silent nosocomial outbreak including 36 to 44% of the CDAD episodes in the three high-incidence wards.


Asunto(s)
Clostridioides difficile , Infección Hospitalaria/microbiología , Enterocolitis Seudomembranosa/epidemiología , Clostridioides difficile/clasificación , Clostridioides difficile/genética , Clostridioides difficile/aislamiento & purificación , Diarrea/epidemiología , Diarrea/microbiología , Heces/microbiología , Humanos , Pacientes Internos/estadística & datos numéricos , Epidemiología Molecular/métodos , Recurrencia , Suecia/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...